
April to June 2024
| Drug Name | Government Contribution Dollars | Prescriptions |
|---|---|---|
| PEMBROLIZUMAB | $161,665,638 | 19,101 |
| ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR | $141,017,701 | 6,596 |
| MOLNUPIRAVIR | $123,404,075 | 106,490 |
| USTEKINUMAB | $115,410,487 | 16,226 |
| NIVOLUMAB | $111,940,309 | 15,455 |
| AFLIBERCEPT | $109,119,641 | 111,703 |
| DUPILUMAB | $102,613,557 | 59,816 |
| NIRMATRELVIR (&) RITONAVIR | $98,791,084 | 82,006 |
| APIXABAN | $88,873,762 | 1,055,439 |
| DENOSUMAB | $78,517,870 | 313,373 |
| SEMAGLUTIDE | $76,827,055 | 651,954 |
| UPADACITINIB | $60,526,430 | 42,241 |
| Drug Name | Government Contribution Dollars | Prescriptions |
|---|---|---|
| ROSUVASTATIN | $26,722,244 | 4,103,876 |
| ATORVASTATIN | $20,448,379 | 2,824,219 |
| PANTOPRAZOLE | $19,605,838 | 2,750,792 |
| ESOMEPRAZOLE | $16,682,820 | 2,055,341 |
| PERINDOPRIL | $10,612,436 | 1,660,150 |
| ESCITALOPRAM | $6,564,076 | 1,627,613 |
| SERTRALINE | $6,805,868 | 1,537,545 |
| METFORMIN | $10,675,327 | 1,526,190 |
| AMOXICILLIN | $5,288,590 | 1,443,624 |
| CEFALEXIN | $6,292,638 | 1,284,059 |
| AMLODIPINE | $7,839,303 | 1,186,922 |
| TELMISARTAN | $6,428,737 | 1,069,379 |
| Contributor | Contribution Dollars |
|---|---|
| Australian Government | $4,617,613,918 |
| Patients | $964,017,183 |